Antibody guided lymphangiography in the staging of cervical cancer.

por Epenetos, A. A.
Publicado 1985

Dr Epenetos replies

por Epenetos, A.A.
Publicado 1986

Immunoscintigraphy, Practical Aspects and Clinical Applications

por Maraveyas, A., Epenetos, A.A.
Publicado 1992

Monoclonal antibodies for imaging and therapy.

por Epenetos, A. A., Kosmas, C.
Publicado 1989

Targeting enzymes for cancer therapy: old enzymes in new roles.

por Deonarain, M. P., Epenetos, A. A.
Publicado 1994

Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.

por Deonarain, M. P., Epenetos, A. A.
Publicado 1998

Patients receiving murine monoclonal antibody therapy for malignancy develop T cells that proliferate in vitro in response to these antibodies as antigens.

por Kosmas, C., Epenetos, A. A., Courtenay-Luck, N. S.
Publicado 1991

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.

por Rowlinson-Busza, G., Maraveyas, A., Epenetos, A. A.
Publicado 1995

A recombinant single chain antibody interleukin-2 fusion protein.

por Savage, P., So, A., Spooner, R. A., Epenetos, A. A.
Publicado 1993

Immunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies.

por Sivolapenko, G. B., Kanariou, M., Edwards, R. J., Epenetos, A. A., Ritter, M. A.
Publicado 1989

Development of a novel bi-specific monoclonal antibody approach for tumour targeting

por Koumarianou, A A, Hudson, M, Williams, R, Epenetos, A A, Stamp, G W H
Publicado 1999

Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1

por Pericleous, L M, Richards, J, Epenetos, A A, Courtenay-Luck, N, Deonarain, M P
Publicado 2005

Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjug...

por Sivolapenko, G. B., Moreno, C., Smith, W., Corválan, J., Ritter, M. A., Epenetos, A. A.
Publicado 1991

An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase.

por Epenetos, A. A., Travers, P., Gatter, K. C., Oliver, R. D., Mason, D. Y., Bodmer, W. F.
Publicado 1984

Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

por Al Jabaari, B., Ladyman, H. M., Larché, M., Sivolapenko, G. B., Epenetos, A. A., Ritter, M. A.
Publicado 1989

Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase.

por Savage, P., Rowlinson-Busza, G., Verhoeyen, M., Spooner, R. A., So, A., Windust, J., Davis, P. J., Epenetos, A. A.
Publicado 1993

A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.

por Dhokia, B., Pectasides, D., Self, C., Habib, N. A., Hershman, M., Wood, C. B., Munro, A. J., Epenetos, A. A.
Publicado 1986

A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.

por Dhokia, B., Canney, P. A., Pectasides, D., Munro, A. J., Moore, M., Wilkinson, P. M., Self, C., Epenetos, A. A.
Publicado 1986

Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.

por Epenetos, A. A., Nimmon, C. C., Arklie, J., Elliott, A. T., Hawkins, L. A., Knowles, R. W., Britton, K. E., Bodmer, W. F.
Publicado 1982

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.

por Hird, V., Maraveyas, A., Snook, D., Dhokia, B., Soutter, W. P., Meares, C., Stewart, J. S., Mason, P., Lambert, H. E., Epenetos, A. A.
Publicado 1993